Abstract
CpG DNA is DNA sequence that has immune stimulatory effects. Several lines of investigation over the past few years indicate that CpG DNA plays an important role in the induction of immune responses to DNA vaccines. In this study, CpG DNA-containing synthetic oligodeoxynucleotide (CpG-ODN) was cloned into the eukaryotic expression plasmid encoding a fusion protein containing β-galactosidase fromE. coli and immunogenic epitopes of foot- and-mouth disease virus (FMDV) type O, and the immune responses induced by the plasmid were assayed. The results showed that guinea pigs immunized with the recombinant plasmid containing CpG-ODN generated a higher level of FMDV-neutralizing antibody and a stronger T cell proliferative response and protection against viral challenge than those receiving the plasmid containing no CpG-ODN. Our study demonstrated that it is an effective route to enhance the efficacy of DNA vaccines by inserting exogenous CpG DNA into the plasmids, and the DNA vaccine developed here is a promising candidate to prevent FMDV infection.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Yamamoto, S., Yamamoto, T., Kataoka T. et al., Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity, J. Immunol., 1992, 148: 4072.
Krieg, A. M., Yi, A-K., Matson, S. et al., CpG motifs in bacterial DNA trigger direct B-cell activation, Nature, 1995, 374: 546.
Klinman, D. M., Yi, A-K., Beaucage, S. L. et al., CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ, Proc. Natl. Acad. Sci. USA., 1996, 13: 2879.
Hartmann, G., Weiner, G., Krieg, A. M., CpG DNA as a signal for growth, activation and maturation of human dendritic cells, Proc. Natl. Acad. Sci. USA., 1999, 96: 9305.
Sato, Y., Roman, M., Tighe, H. et al., Immunostimulatory DNA sequences necessary for effective intradermal gene immunization, Science, 1996, 273: 352.
Klinman, D. M., Yamshchikov, G., Ishigatsubo, Y., Contribution of CpG motifs to the immunogenicity of DNA vaccines, J. Immunol., 1997, 158: 3635.
Tighe, H., Corr, M., Roman, M. et al., Gene vaccination: plasmid DNA is more than just a blueprint, Immunology Today, 1998, 19: 89.
Zhao, K., Zheng, Z. X., Cloning, sequencing and expression of a swine IgG H chain gene inE. coli, Chinese Science Bulletin, 1999, 44(9): 821.
Mclcahy, G., Pullen, L. A., Gale, C. et al., Mouse protection test as a predictor of the protective capacity of synthetic foot- and mouth disease vaccines, Vaccine, 1991, 9: 19.
Tokunaga, T., Yamamoto, H., Shimada, S. et al., Antitumor activity of deoxyribonucleic acid fraction frommycobacterium bovis BCG, I. Isolation, physicochemical characterization, and antitumor activity, J. Natl. Cancer Inst., 1984, 72: 955.
Millan, C. L. B., Weeratna, R., Krieg, A. M. et al., CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice, Proc. Natl. Acad. Sci. USA., 1998, 95: 15553.
Weiner, G. J., Liu, H. M., Wooldridge, J. E. et al., Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization, Proc. Natl. Acad. Sci. USA., 1997, 94: 10833.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Li, G., Li, Y., Yan, W. et al. CpG DNA enhances the immune responses elicited by the DNA vaccine against foot-and-mouth disease virus in guinea pigs. Chin.Sci.Bull. 46, 1376–1379 (2001). https://doi.org/10.1007/BF03183393
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03183393